Navigation Links
Teriflunomide Successfully Reduces Relapses and is Well Tolerated in Multiple Sclerosis Patients
Date:10/15/2010

for the treatment of multiple sclerosis with a comprehensive clinical development program which has been launched in monotherapy. First Phase II study results of the safety and efficacy of teriflunomide monotherapy in MS were published in Neurology in 2006. In addition to the TEMSO trial, two other Phase III trials, TOWER and TENERE, are ongoing in RMS patients. A Phase III study, TOPIC, is also underway in early MS or CIS (Clinically isolated syndrome). Teriflunomide has also been evaluated as an adjunct therapy to either interferon beta or glatiramer acetate in two Phase II studies. Results of these studies were presented earlier this year during the American Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and American Academy of Neurology (AAN) meetings respectively. Phase II studies with teriflunomide (7 and 14mg) in adjunct with IFNbeta demonstrated an improvement in MRI outcomes, with a consistent safety profile in patients treated with the adjunct therapy compared to patients treated with IFNbeta and receiving placebo. In the other Phase II study, teriflunomide in adjunct to glatiramer acetate (GA) was well-tolerated compared to patients receiving GA and placebo and showed a numerical trend for the reduction in number and volume of gadolinium enhancing T-1 brain MRI lesions in the adjunct arm compared to the placebo with GA arm.

About the TEMSO Study

TEMSO is a 2-year randomized, double-blind, placebo-controlled multinational study including 1,088 RMS patients aged 18-55 years from 21 countries, with an Expanded Disability Status Scale (EDSS) is less than or equal to 5.5 and at least one relapse in the previous year or at least 2 relapses in the preceding 2 years. Patients were randomized to placebo or teriflunomide, 7 or 14mg, once daily and followed for 108 weeks. The primary endpoint was annualized relapse rate defined as the number of confirmed relapses per patient-year. The key secondary endpoint was the time to sust
'/>"/>

SOURCE Sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Medisafe 1 Technologies Successfully Tests Prototype of Patented Syringe Locking Device
2. Endo Pharmaceuticals Successfully Completes Tender Offer for Shares of Penwest Pharmaceuticals
3. Transcatheter Technologies Successfully Performs in Vivo Implantation of the Trinity Transapical Aortic Valve System
4. Omeros Successfully Unlocks Orphan GPCRs
5. NeuroDerm Successfully Completes Enrollment and Dosing in a Phase 1 Clinical Study of ND0611 Dermal Patch for Parkinsons Disease
6. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
7. MedAvante Opens Moscow Office and Successfully Completes First Centralized Ratings Assessment
8. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
9. Sanofi-aventis Successfully Completes The Acquisition of Chattem, Inc.
10. Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.
11. Phonak Successfully Hosts Hearing Care for Adults 2009 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  A prospective study ... Sweden has validated the performance of ... and has associated volumetrically assessed breast density measurements ... Epidemiology, Biomarkers & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the ... tool for widespread breast cancer risk assessment," was ...
(Date:7/28/2014)... July 28, 2014  TNI BioTech, Inc. (OTCQB: ... focused on the development, marketing and distribution of ... definitive proxy materials with the Securities and Exchange ... of Shareholders to be held on Thursday, September ... The record date for determining those shareholders eligible ...
(Date:7/28/2014)...  ResMed (NYSE: RMD ), an innovator ... sleep-disordered breathing and other chronic respiratory conditions, has won ... against Taiwanese medical device manufacturer APEX Medical Corp. (APEX), ... 210 and 220 masks.  The judgment was entered by ... , is appealable, and applies throughout Germany.  ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2
... Calif., Oct. 31, 2011 Claret Medical, Inc. announced ... approval as the world,s first complete system of filtration ... is delivered via radial or brachial access, providing complete ... Valve Intervention (TAVI).  The unique design of the Montage ...
... Oct. 31, 2011 At the American ... Renal Research Institute, LLC (RRI) is presenting research results from ... dedicated to advancing therapy options for dialysis patients to provide ... ASN,s Kidney Week 2011 takes place Nov. 8-13 in Philadelphia, ...
Cached Medicine Technology:Claret Medical Announces CE Mark of a New Embolic Protection System to Address Stroke During Transcatheter Aortic Valve Intervention 2Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week 2Renal Research Institute Announces Scientific Presentations at the American Society of Nephrology Kidney Week 3
(Date:7/28/2014)... new study of the European project SOPHIE has ... policies and gender inequalities in health in Europe. ... policies (central and southern Europe) and countries with ... self-perceived health, i.e. women reported poorer health than ... Europe countries, where women present a 27% higher ...
(Date:7/28/2014)... CA (PRWEB) July 28, 2014 Top ... $100 coupon for new patients. Finding a new dentist can ... or dental issues that have gone untreated and worry about ... Dr. Ariz specializes in patients with special concerns and dental ... feels comfortable and right at home. This special coupon can ...
(Date:7/28/2014)... July 28, 2014 What if you ... lifestyle can often be a struggle that requires personal ... and medium, Lynette Leckie-Clark provides simple how-to steps on ... Magic of You.” With inspiring spiritual affirmations and life ... find empowerment, confidence and motivation for everyday life. ...
(Date:7/28/2014)... "I injured my shoulder and had to have ... Sunnyvale, Calif. "When I slept in one, I almost strangled ... and require too many straps. That is why I came ... Vest to improve the design of a standard sling. The ... properly. This helps to speed up the healing process. The ...
(Date:7/28/2014)... Humility of Mary Health Partners will offer a one-hour ... Health Center, 8401 Market St., Boardman. , The workshop includes ... 200 common health problems as well as tips on caring ... advice on when to seek medical attention. , The ... session runs from 5:30 to 6:30 p.m. The workshop and ...
Breaking Medicine News(10 mins):Health News:Gender inequalities in health: A matter of policies 2Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:Be Empowered to Achieve Happiness from New Book "The Magic of You" 2Health News:HMHP Offers ‘Health at Home’ Workshop 2
... is studying the differences between the social impairments found ... for people with both disorders. Autism spectrum disorder ... but they share similarities in social dysfunction. For many ... young people with ASD were thought to have a ...
... heart disease may not be able to compensate for their ... to Penn State researchers, making snow shoveling and other activities ... why cold air is such a trigger for coronary events," ... of the Heart and Vascular Institute, Penn State College of ...
... LANSING, Mich. Often faced with overwhelming anxiety, patients newly ... new research recommends nurses play a key role in alleviating ... A diagnosis of lung cancer the leading cause ... it high levels of stress and raises existential issues and ...
... , TUESDAY, Feb. 28 (HealthDay News) -- ... the chances that those addicted to opioids who have ... habit, a new study shows. Opioid abuse includes ... and the nonmedical use of prescription painkillers such as ...
... BLOOMINGTON, Ind. -- U.S. industry and environmental groups agree ... needs to be modernized to better protect public health ... what the reform should look like. A new ... the European Union,s reformed chemicals law REACH (Registration, Evaluation, ...
... deal has been learned in the ten years since the ... therapy (HT) remains the most effective treatment available for menopausal ... body of evidence that formulation, route of administration, timing of ... It is essential to evaluate a personal benefit-risk profile ...
Cached Medicine News:Health News:Study compares traits of autism, schizophrenia 2Health News:Cold air chills heart's oxygen supply 2Health News:Nurses key in helping new cancer patients overcome fears 2Health News:Drug-Free Housing Helps Heroin, Oxycontin Addicts Recover 2Health News:Report examines what US can learn from EU chemicals law 2Health News:The North American Menopause Society (NAMS) reassures many women 2
Lumicon 48 mm red filter....
Doctors six-pack long lasting, disposable, diagnostic penlights. Constant use time of 30 minutes. One year shelf life warranty from date of purchase. Convenient clip-activated switch & imprinted medi...
Features a twist-on backswitch with a diffused, cobalt blue, light beam. Packaged with fluorescein strips....
... integrates the latest in auto focus. The ... computer monitors or televisions to create a ... individuals unique viewing needs. Using advanced technology ... the Genie Pro allows a user to ...
Medicine Products: